Utah Medical Products Statistics
Total Valuation
UTMD has a market cap or net worth of $230.64 million. The enterprise value is $141.69 million.
Important Dates
The next estimated earnings date is Thursday, October 24, 2024, before market open.
| Earnings Date | Oct 24, 2024 |
| Ex-Dividend Date | Sep 20, 2024 |
Share Statistics
UTMD has 3.48 million shares outstanding. The number of shares has decreased by -0.70% in one year.
| Shares Outstanding | 3.48M |
| Shares Change (YoY) | -0.70% |
| Shares Change (QoQ) | -2.39% |
| Owned by Insiders (%) | 6.72% |
| Owned by Institutions (%) | 65.47% |
| Float | 3.02M |
Valuation Ratios
The trailing PE ratio is 15.30.
| PE Ratio | 15.30 |
| Forward PE | n/a |
| PS Ratio | 5.13 |
| Forward PS | n/a |
| PB Ratio | 1.87 |
| P/FCF Ratio | 12.75 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.52, with an EV/FCF ratio of 7.84.
| EV / Earnings | 9.07 |
| EV / Sales | 3.04 |
| EV / EBITDA | 6.52 |
| EV / EBIT | 8.06 |
| EV / FCF | 7.84 |
Financial Position
The company has a current ratio of 25.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 25.98 |
| Quick Ratio | 23.58 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 12.72% and return on invested capital (ROIC) is 8.92%.
| Return on Equity (ROE) | 12.72% |
| Return on Assets (ROA) | 8.44% |
| Return on Capital (ROIC) | 8.92% |
| Revenue Per Employee | $245,147 |
| Profits Per Employee | $82,263 |
| Employee Count | 190 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.99 |
Taxes
In the past 12 months, UTMD has paid $3.18 million in taxes.
| Income Tax | 3.18M |
| Effective Tax Rate | 16.89% |
Stock Price Statistics
The stock price has decreased by -23.80% in the last 52 weeks. The beta is 0.08, so UTMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -23.80% |
| 50-Day Moving Average | 66.77 |
| 200-Day Moving Average | 70.27 |
| Relative Strength Index (RSI) | 49.89 |
| Average Volume (20 Days) | 20,518 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, UTMD had revenue of $46.58 million and earned $15.63 million in profits. Earnings per share was $4.34.
| Revenue | 46.58M |
| Gross Profit | 27.48M |
| Operating Income | 17.58M |
| Pretax Income | 18.81M |
| Net Income | 15.63M |
| EBITDA | 21.73M |
| EBIT | 17.58M |
| Earnings Per Share (EPS) | $4.34 |
Full Income StatementBalance Sheet
The company has $89.22 million in cash and $275,000 in debt, giving a net cash position of $88.94 million or $25.58 per share.
| Cash & Cash Equivalents | 89.22M |
| Total Debt | 275,000 |
| Net Cash | 88.94M |
| Net Cash Per Share | $25.58 |
| Equity (Book Value) | 124.05M |
| Book Value Per Share | 35.45 |
| Working Capital | 98.38M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $18.49 million and capital expenditures -$408,000, giving a free cash flow of $18.08 million.
| Operating Cash Flow | 18.49M |
| Capital Expenditures | -408,000 |
| Free Cash Flow | 18.08M |
| FCF Per Share | $5.20 |
Full Cash Flow StatementMargins
Gross margin is 58.99%, with operating and profit margins of 37.75% and 33.56%.
| Gross Margin | 58.99% |
| Operating Margin | 37.75% |
| Pretax Margin | 40.38% |
| Profit Margin | 33.56% |
| EBITDA Margin | 46.66% |
| EBIT Margin | 37.75% |
| FCF Margin | 38.88% |